TY - JOUR
T1 - Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases
AU - Dezawa, Mari
AU - Ishikawa, Hiroto
AU - Hoshino, Mikio
AU - Itokazu, Yutaka
AU - Nabeshima, Yo Ichi
PY - 2005/10
Y1 - 2005/10
N2 - Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinson's disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSC-derived cells and discuss the possibility of clinical application in degenerative diseases.
AB - Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinson's disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSC-derived cells and discuss the possibility of clinical application in degenerative diseases.
KW - Cell therapy
KW - Mesenchymal cell
KW - Myogenic differentiation
KW - Neuronal differentiation
KW - Regenerative medicine
KW - Schwann cells
KW - Transdifferentiation
KW - Transplantation
UR - http://www.scopus.com/inward/record.url?scp=26844489638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=26844489638&partnerID=8YFLogxK
U2 - 10.2174/157015905774322507
DO - 10.2174/157015905774322507
M3 - Review article
AN - SCOPUS:26844489638
SN - 1570-159X
VL - 3
SP - 257
EP - 266
JO - Current Neuropharmacology
JF - Current Neuropharmacology
IS - 4
ER -